相关实验视频

Updated: Jul 5, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

在中国北京,人类乳头瘤病毒感染的流行病学和基因型分析

Jiao Wang¹, Haotian Li¹, Jieqiong Zhang¹

¹National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.

Virology journal

|January 16, 2024

概括

高风险的人类乳头瘤病毒 (HPV) 影响北京24.1%的女性,HPV16与子宫病变密切相关. 预防策略应考虑区域HPV流行率和特定年龄的感染率.

科学领域:

妇科妇科妇科妇科
流行病学流行病学
病毒学病毒学

背景情况:

在中国北京市的女性人口中调查高风险人乳头瘤病毒 (HPV) 的患病率和特征.
了解特定HPV基因型与宿主因素之间的关系对于公共卫生至关重要.
评估HPV的流行病情景对于有针对性的预防和控制策略至关重要.

研究的目的:

在北京的女性人口中确定高风险HPV的流行病学.
为了确定HPV基因型和宿主因子之间的相关性,包括宫细胞学.
为HPV预防和管理提供公共卫生倡议的信息.

主要方法:

在2020年期间,在北京对25344名年龄在15-89岁的女性进行了HPV测试.
利用高风险的HPV基因型定型实时聚合酶链反应来确定基因型.
分析了整体和特定年龄的患病率,基因型分布,以及与宫细胞学的关联.

主要成果:

总体高风险HPV患病率为24.1%,其中HPV52,HPV58,HPV16,HPV39和HPV51是最常见的.
随着年龄的增长,HPV感染率增加,在25岁以下的女性和55-59岁的女性中呈现出明显的高峰.
HPV16与宫细胞学严重程度和病变进展有很强的关联.

结论:

单一的高风险HPV感染占主导地位,HPV16对宫病变的进展造成了重大关注.
根据年龄,HPV感染率有很大差异,这表明疫苗接种和查计划应该根据区域HPV分布量身定制.
北京的公共卫生干预措施应针对HPV39等特定基因型,并考虑特定年龄的风险因素,以有效预防和治疗.

关键词:

年代年代年代年代宫癌是发生在宫癌的原因之一.宫病变宫病变宫病变集群分析就是对集群进行分析.高风险的HPV病毒

更多相关视频

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...